ArticleFrontiers in bioengineering and biotechnology2026
Biomimetic core-shell nanofibrous scaffolds with an organic montmorillonite interlayer for tissue engineering.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrospun polymer nanofibrous scaffolds have gained considerable interest in biomedical applications due to their ability to mimic the architecture and biological functions of the extracellular matrix (ECM). However, precise control over scaffold degradation is essential for ensuring predictable material behavior and supporting their intended function in tissue engineering. In this study, we develop a series of core-shell nanofibrous scaffolds composed of glycidyl methacrylate-grafted silk fibroin and poly(L-lactide-co-caprolactone) (SFMA/PLCL), incorporating an interlayer of organically modified montmorillonite (OMMT). The introduction of OMMT markedly enhances scaffold hydrophilicity, mechanical robustness, and dimensional stability, while enabling finely tunable degradation kinetics. Increasing OMMT content shifts the degradation mode from surface erosion to bulk degradation by facilitating water penetration and disrupting polymer interactions through exfoliated OMMT nanosheets and the release of quaternary ammonium ions. Moreover, the scaffolds exhibit potent antibacterial activity (>99% inhibition against Staphylococcus aureus), strong anti-biofilm performance (>75% suppression), and long-lasting antibacterial effects, all while maintaining excellent cytocompatibility. These results demonstrate that core-shell nanofibrous scaffolds with an OMMT interlayer represent a promising multifunctional platform for tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.